Parvalbumin interneuron deficiency in the prefrontal and motor cortices of spontaneously hypertensive rats: an attention-deficit hyperactivity disorder animal model insight
Bogdańska-Chomczyk, Ewelina, Równiak, Maciej, Huang, Andrew Chih-Wei, Kozłowska, Anna
Published in Frontiers in psychiatry (27.03.2024)
Published in Frontiers in psychiatry (27.03.2024)
Get full text
Journal Article
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial
Roboz, Gail J, Döhner, Hartmut, Pocock, Christopher, Dombret, Herve, Ravandi, Farhad, Jang, Jun Ho, Selleslag, Dominik, Mayer, Jiři, Martens, Uwe M, Liesveld, Jane, Bernal, Teresa, Wang, Ming Chung, Yu, Peiwen, Shi, Ling, Guo, Shien, La Torre, Ignazia, Skikne, Barry, Dong, Qian, Braverman, Julia, Nehme, Salem Abi, Beach, C L, Wei, Andrew H
Published in Haematologica (Roma) (01.12.2021)
Published in Haematologica (Roma) (01.12.2021)
Get full text
Journal Article
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
de Botton, Stéphane, Fenaux, Pierre, Yee, Karen, Récher, Christian, Wei, Andrew H., Montesinos, Pau, Taussig, David C., Pigneux, Arnaud, Braun, Thorsten, Curti, Antonio, Grove, Carolyn, Jonas, Brian A., Khwaja, Asim, Legrand, Ollivier, Peterlin, Pierre, Arnan, Montserrat, Blum, William, Cilloni, Daniela, Hiwase, Devendra K., Jurcic, Joseph G., Krauter, Jürgen, Thomas, Xavier, Watts, Justin M., Yang, Jay, Polyanskaya, Olga, Brevard, Julie, Sweeney, Jennifer, Barrett, Emma, Cortes, Jorge
Published in Blood advances (11.07.2023)
Published in Blood advances (11.07.2023)
Get full text
Journal Article
Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population
Hein, Nadine, Cameron, Donald P., Hannan, Katherine M., Nguyen, Nhu-Y N., Fong, Chun Yew, Sornkom, Jirawas, Wall, Meaghan, Pavy, Megan, Cullinane, Carleen, Diesch, Jeannine, Devlin, Jennifer R., George, Amee J., Sanij, Elaine, Quin, Jaclyn, Poortinga, Gretchen, Verbrugge, Inge, Baker, Adele, Drygin, Denis, Harrison, Simon J., Rozario, James D., Powell, Jason A., Pitson, Stuart M., Zuber, Johannes, Johnstone, Ricky W., Dawson, Mark A., Guthridge, Mark A., Wei, Andrew, McArthur, Grant A., Pearson, Richard B., Hannan, Ross D.
Published in Blood (25.05.2017)
Published in Blood (25.05.2017)
Get full text
Journal Article
In vivo Efficacy of the Bcl-2 Antagonist ABT-737 against Aggressive Myc-Driven Lymphomas
Mason, Kylie D., Vandenberg, Cassandra J., Scott, Clare L., Wei, Andrew H., Cory, Suzanne, Huang, David C. S., Roberts, Andrew W.
Published in Proceedings of the National Academy of Sciences - PNAS (18.11.2008)
Published in Proceedings of the National Academy of Sciences - PNAS (18.11.2008)
Get full text
Journal Article
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts
Appelbaum, Jacob S., Wei, Andrew H., Mandrekar, Sumithra J., Tiong, Ing S., Chua, Chong Chyn, Teh, Tse-Chieh, Fong, Chun Yew, Ting, Stephen B., Weber, Daniela, Benner, Axel, Hill, Hannah, Saadati, Maral, Yin, Jun, Stone, Richard M., Garcia-Manero, Guillermo, Erba, Harry P., Uy, Geoffrey L., Marcucci, Guido, Larson, Richard A., Thomas, Abin, Freeman, Sylvie D., Almuina, Nuria Marquez, Döhner, Konstanze, Thomas, Ian, Russel, Nigel H., Döhner, Hartmut, Othus, Megan, Estey, Elihu H., Walter, Roland B.
Published in Leukemia (01.02.2024)
Published in Leukemia (01.02.2024)
Get full text
Journal Article
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
Zeidan, Amer M., Bewersdorf, Jan Philipp, Buckstein, Rena, Sekeres, Mikkael A., Steensma, David P., Platzbecker, Uwe, Loghavi, Sanam, Boultwood, Jacqueline, Bejar, Rafael, Bennett, John M., Borate, Uma, Brunner, Andrew M., Carraway, Hetty, Churpek, Jane E., Daver, Naval G., Della Porta, Matteo, DeZern, Amy E., Efficace, Fabio, Fenaux, Pierre, Figueroa, Maria E., Greenberg, Peter, Griffiths, Elizabeth A., Halene, Stephanie, Hasserjian, Robert P., Hourigan, Christopher S., Kim, Nina, Kim, Tae Kon, Komrokji, Rami S., Kutchroo, Vijay, List, Alan F., Little, Richard F., Majeti, Ravi, Nazha, Aziz, Nimer, Stephen D., Odenike, Olatoyosi, Padron, Eric, Patnaik, Mrinal M., Roboz, Gail J., Sallman, David A., Sanz, Guillermo, Stahl, Maximilian, Starczynowski, Daniel T., Taylor, Justin, Xie, Zhuoer, Xu, Mina, Savona, Michael R., Wei, Andrew H., Abdel-Wahab, Omar, Santini, Valeria
Published in Leukemia (01.12.2022)
Published in Leukemia (01.12.2022)
Get full text
Journal Article
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes
Brunner, Andrew M., Esteve, Jordi, Porkka, Kimmo, Knapper, Steve, Traer, Elie, Scholl, Sebastian, Garcia‐Manero, Guillermo, Vey, Norbert, Wermke, Martin, Janssen, Jeroen J. W. M., Narayan, Rupa, Fleming, Shaun, Loo, Sun, Tovar, Natalia, Kontro, Mika, Ottmann, Oliver G., Naidu, Purushotham, Sun, Haiying, Han, May, White, Roisin, Zhang, Na, Mohammed, Anisa, Sabatos‐Peyton, Catherine A., Steensma, David P., Rinne, Mikael L., Borate, Uma M., Wei, Andrew H.
Published in American journal of hematology (01.02.2024)
Published in American journal of hematology (01.02.2024)
Get full text
Journal Article
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies
Germon, Zacary P, Sillar, Jonathan R, Mannan, Abdul, Duchatel, Ryan J, Staudt, Dilana, Murray, Heather C, Findlay, Izac J, Jackson, Evangeline R, McEwen, Holly P, Douglas, Alicia M, McLachlan, Tabitha, Schjenken, John E, Skerrett-Byrne, David A, Huang, Honggang, Melo-Braga, Marcella N, Plank, Maximilian W, Alvaro, Frank, Chamberlain, Janis, De Iuliis, Geoff, Aitken, R John, Nixon, Brett, Wei, Andrew H, Enjeti, Anoop K, Huang, Yizhou, Lock, Richard B, Larsen, Martin R, Lee, Heather, Vaghjiani, Vijesh, Cain, Jason E, de Bock, Charles E, Verrills, Nicole M, Dun, Matthew D
Published in Science signaling (28.03.2023)
Published in Science signaling (28.03.2023)
Get more information
Journal Article
Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms
Shah, Mithun Vinod, Chhetri, Rakchha, Dholakia, Ruchita, Kok, Chung H., Gangat, Naseema, Alkhateeb, Hassan B., Al‐Kali, Aref, Patnaik, Mrinal M., Baranwal, Anmol, Greipp, Patricia T., He, Rong, Begna, Kebede H., Tiong, Ing Soo, Wei, Andrew H., Hiwase, Devendra
Published in American journal of hematology (01.08.2022)
Published in American journal of hematology (01.08.2022)
Get full text
Journal Article
Idasanutlin Plus Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia: Results of the MIRROS Trial
Konopleva, Marina Y., Röllig, Christoph, Cavenagh, Jamie, Deeren, Dries, Girshova, Larisa, Krauter, Jürgen, Martinelli, Giovanni, Montesinos, Pau, Schäfer, Jonas A., Ottmann, Oliver, Petrini, Mario, Pigneux, Arnaud, Rambaldi, Alessandro, Recher, Christian, Rodriguez-Veiga, Rebeca, Taussig, David, Vey, Norbert, Yoon, Sung-Soo, Ott, Marion, Muehlbauer, Susanne, Beckermann, Benjamin M., Catalani, Olivier, Genevray, Magali, Mundt, Kirsten, Jamois, Candice, Fenaux, Pierre, Wei, Andrew H.
Published in Blood advances (26.07.2022)
Published in Blood advances (26.07.2022)
Get full text
Journal Article
Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial
Wei, Andrew H., Döhner, Hartmut, Sayar, Hamid, Ravandi, Farhad, Montesinos, Pau, Dombret, Hervé, Selleslag, Dominik, Porkka, Kimmo, Jang, Jun‐Ho, Skikne, Barry, Beach, C. L., Prebet, Thomas, Zhang, George, Risueño, Alberto, Ugidos, Manuel, See, Wendy L., Menezes, Daniel, Roboz, Gail J.
Published in American journal of hematology (01.04.2023)
Published in American journal of hematology (01.04.2023)
Get full text
Journal Article
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial
Dillon, Richard, Maycock, Shanna, Jackson, Aimee, Fox, Sonia, Freeman, Sylvie, Craddock, Charles, Thomas, Catherine, Homer, Emma, Leahy, Jane, Mamwell, Anna, Potter, Nicola, Russell, Nigel, Wei, Andrew, Ommen, Hans Beier, Hemmaway, Claire, Knapper, Steve, Billingham, Lucinda
Published in BMC cancer (14.11.2022)
Published in BMC cancer (14.11.2022)
Get full text
Journal Article
Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
Jonas, Brian A., Wei, Andrew H., Recher, Christian, DiNardo, Courtney D., Jang, Jun‐Ho, Pratz, Keith, Panayiotidis, Panayiotis, Montesinos, Pau, Yeh, Su‐Peng, Ivanov, Vladimir, Fiedler, Walter, Yamauchi, Takahiro, Duan, Yinghui, Mendes, Wellington, Potluri, Jalaja, Tews, Björn, Ofran, Yishai
Published in American journal of hematology (01.08.2022)
Published in American journal of hematology (01.08.2022)
Get full text
Journal Article
Androgens stimulate erythropoiesis through the DNA‐binding activity of the androgen receptor in non‐hematopoietic cells
McManus, Julie F., Nguyen, Nhu‐Y N., Davey, Rachel A., MacLean, Helen E., Pomilio, Giovanna, McCormack, Matthew P., Chiu, Wan Sze, Wei, Andrew H., Zajac, Jeffrey D., Curtis, David J.
Published in European journal of haematology (01.09.2020)
Published in European journal of haematology (01.09.2020)
Get full text
Journal Article
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial
Ravandi, Farhad, Roboz, Gail J., Wei, Andrew H., Döhner, Hartmut, Pocock, Christopher, Selleslag, Dominik, Montesinos, Pau, Sayar, Hamid, Musso, Maurizio, Figuera-Alvarez, Angela, Safah, Hana, Tse, William, Sohn, Sang Kyun, Hiwase, Devendra, Chevassut, Timothy, Pierdomenico, Francesca, La Torre, Ignazia, Skikne, Barry, Bailey, Rochelle, Zhong, Jianhua, Beach, C. L., Dombret, Herve
Published in Journal of hematology and oncology (28.08.2021)
Published in Journal of hematology and oncology (28.08.2021)
Get full text
Journal Article
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
Wei, Andrew H., Panayiotidis, Panayiotis, Montesinos, Pau, Laribi, Kamel, Ivanov, Vladimir, Kim, Inho, Novak, Jan, Stevens, Don A., Fiedler, Walter, Pagoni, Maria, Bergeron, Julie, Ting, Stephen B., Hou, Jing-Zhou, Anagnostopoulos, Achilles, McDonald, Andrew, Murthy, Vidhya, Yamauchi, Takahiro, Wang, Jianxiang, Chyla, Brenda, Sun, Yan, Jiang, Qi, Mendes, Wellington, Hayslip, John, DiNardo, Courtney D.
Published in Blood cancer journal (New York) (01.10.2021)
Published in Blood cancer journal (New York) (01.10.2021)
Get full text
Journal Article
Validation of Patient Health Questionnaire for depression screening among primary care patients in Taiwan
Liu, Shen-Ing, Yeh, Zai-Ting, Huang, Hui-Chun, Sun, Fang-Ju, Tjung, Jin-Jin, Hwang, Lee-Ching, Shih, Yang-Hsien, Yeh, Andrew Wei-Chiang
Published in Comprehensive psychiatry (2011)
Published in Comprehensive psychiatry (2011)
Get full text
Journal Article
Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML
Rijal, Sewa, Fleming, Shaun, Cummings, Nik, Rynkiewicz, Natalie K., Ooms, Lisa M., Nguyen, Nhu-Y. N., Teh, Tse-Chieh, Avery, Sharon, McManus, Julie F., Papenfuss, Anthony T., McLean, Catriona, Guthridge, Mark A., Mitchell, Christina A., Wei, Andrew H.
Published in Blood (30.04.2015)
Published in Blood (30.04.2015)
Get full text
Journal Article